{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:31Z","timestamp":1792791451262,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.mycmed.2017.04.011","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T19:16:11Z","timestamp":1494011771000},"page":"351-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Luliconazole, an alternative antifungal agent against Aspergillus terreus"],"prefix":"10.1016","volume":"27","author":[{"given":"M.","family":"Zargaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Taghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kiasat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Aboualigalehdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rezaei-Matehkolaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zarei Mahmoudabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Shamsizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2017.04.011_bib0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijantimicag.2014.07.002","article-title":"Treatment of Aspergillus terreus infections: a clinical problem not yet resolved","volume":"44","author":"Pastor","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0265","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.jtcvs.2014.06.084","article-title":"Successful surgical treatment of rare Aspergillus terreus prosthetic valve endocarditis complicated by intracranial and mesenteric artery mycotic aneurysms","volume":"148","author":"Ahmad","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11046-016-0007-6","article-title":"Spondylodiscitis due to Aspergillus terreus in an immunocompetent host: case report and literature review","volume":"181","author":"Comacle","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0275","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/00365540510036598","article-title":"Aspergillus terreus endophthalmitis","volume":"37","author":"Bradley","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0280","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4103\/0301-4738.141065","article-title":"Aspergillus terreus endogenous endophthalmitis: report of a case and review of literature","volume":"62","author":"Panigrahi","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/myc.12061","article-title":"Aspergillus terreus complex: an emergent opportunistic agent of onychomycosis","volume":"56","author":"Fernandez","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11046-011-9427-5","article-title":"Otomycosis due to filamentous fungi","volume":"172","author":"Garc\u00eda-Agudo","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0295","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/myc.12165","article-title":"Aspergillosis of bones and joints\u00a0\u2013\u00a0a review from 2002 until today","volume":"57","author":"Koehler","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0300","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1086\/317467","article-title":"Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: case report and review","volume":"31","author":"Silva","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0305","first-page":"275","article-title":"Aspergillus terreus myocarditis: report of a case and review of the literature","volume":"3","author":"Russack","year":"1989","journal-title":"Am J Cardiovasc Pathol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11046-014-9829-2","article-title":"Aspergillus terreus infection in a sutureless self-sealing incision made during cataract surgery","volume":"179","author":"Erdem","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/13693780600779401","article-title":"Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology","volume":"44","author":"Lass-Fl\u00f6rl","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0320","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1128\/AAC.00045-15","article-title":"In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto","volume":"59","author":"Fernandez","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0325","first-page":"DC04","article-title":"Comparative evaluation of disc diffusion and E-test with broth micro-dilution in susceptibility testing of amphotericin B, voriconazole and caspofungin against clinical Aspergillus isolates","volume":"9","author":"Gupta","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0330","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","author":"Van Der Linden","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0335","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/0022-1317-49-7-601","article-title":"Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis","volume":"49","author":"Dannaoui","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0340","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0345","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/cid\/civ542","article-title":"Antifungal prophylaxis with posaconazole is effective in preventing invasive fungal infections in acute myeloid leukemia patients during induction and salvage chemotherapy","volume":"61","author":"Wong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0350","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00253-011-3152-3","article-title":"Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum","volume":"90","author":"Khan","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0355","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1128\/AAC.00905-16","article-title":"Aspergillus fumigatus intrinsic fluconazole resistance is due to the naturally occurring T301I substitution in Cyp51Ap","volume":"60","author":"Leonardelli","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0365","first-page":"1073","article-title":"Antifungal resistance in pathogenic fungi","volume":"35","author":"Perea","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0370","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.clinthera.2007.09.015","article-title":"Posaconazole: an extended-spectrum triazole antifungal agent","volume":"29","author":"Schiller","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0375","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0380","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/myc.12477","article-title":"Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections","volume":"59","author":"Heinz","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0385","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/13693780802541518","article-title":"In vitro antifungal activities of luliconazole, a new topical imidazole","volume":"47","author":"Koga","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3314\/jjmm.50.9","article-title":"[Fungicidal activity of liranaftate against dermatophytes]","volume":"50","author":"Oku","year":"2009","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0395","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CE.S49629","article-title":"Luliconazole for the treatment of fungal infections: an evidence-based review","volume":"9","author":"Khanna","year":"2014","journal-title":"Core Evid"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0400","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.13816","article-title":"Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study","author":"Watanabe","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0405","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/AAC.02370-12","article-title":"Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis","volume":"57","author":"Jones","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0410","first-page":"4","article-title":"A general overview on past, present and future antimycotics","author":"Minnebruggen","year":"2010","journal-title":"Open Mycol J"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0415","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and-susceptible Aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimic Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0420","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/JCM.38.5.2010-2014.2000","article-title":"Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus","volume":"38","author":"Khan","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0425","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/377210","article-title":"Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B","volume":"188","author":"Walsh","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0430","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10529-016-2079-2","article-title":"Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants","volume":"38","author":"Elshikh","year":"2016","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0435","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1128\/AAC.00629-08","article-title":"Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era","volume":"52","author":"Guinea","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0440","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mycmed.2016.01.002","article-title":"In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen","volume":"26","author":"Khodavaisy","year":"2016","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0445","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1128\/AAC.00045-15","article-title":"In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto","volume":"59","author":"Fern\u00e1ndez","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0450","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/2047-783X-16-4-145","article-title":"Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin-review of the literature","volume":"16","author":"Karthaus","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0455","first-page":"151","article-title":"Aspergillus terreus-related ureteral obstruction in a diabetic patient","volume":"7","author":"Najafi","year":"2013","journal-title":"Iranian J Kidney Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0460","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/AAC.00736-10","article-title":"In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex","volume":"55","author":"Salas","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0465","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.02661-13","article-title":"Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serum","volume":"58","author":"Elefanti","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/tcrm.2006.2.2.129","article-title":"Voriconazole in the management of nosocomial invasive fungal infections","volume":"2","author":"Pem\u00e1n","year":"2006","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0475","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1128\/AAC.48.10.3715-3719.2004","article-title":"Antifungal therapy of murine Aspergillus terreus infection","volume":"48","author":"Graybill","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0480","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1469-0691.2003.00797.x","article-title":"Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin","volume":"9","author":"Cooke","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0485","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1600-0463.2007.00719.x","article-title":"The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium","volume":"115","author":"Winn","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0490","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0495","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jvim.13795","article-title":"Treatment of disseminated aspergillosis with posaconazole in 10 dogs","volume":"30","author":"Corrigan","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/2047-783X-16-4-145","article-title":"Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature","volume":"16","author":"Karthaus","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0505","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.04.011_bib0510","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/1469-0691.12514","article-title":"Susceptibility testing in Aspergillus species complex","volume":"20","author":"Lass-Fl\u00f6rl","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S115652331730077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S115652331730077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:26Z","timestamp":1792788026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S115652331730077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S115652331730077X"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.04.011","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Luliconazole, an alternative antifungal agent against Aspergillus terreus","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}